Clearside BioMedical Inc. said July 5 that Gerald Cagle stepped down from its board of directors.
Alpharetta, Ga.-based Clearside BioMedical develops pharmacological therapies for blinding eye diseases.
Clearside BioMedical director resigns
Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge
COVID-19 Impact & Recovery: Private Equity
COVID-19 Impact & Recovery: Corporates
COVID-19 Impact & Recovery: Investment Banking
Clearside BioMedical director resigns
- Author Vince Iral
- Theme Healthcare & Pharmaceuticals
- Author
- Vince Iral
- Theme
- Healthcare & Pharmaceuticals